List of Tables
Table 1. Global Human Genetically Engineered Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Human Genetically Engineered Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Human Genetically Engineered Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Genetically Engineered Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Human Genetically Engineered Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Human Genetically Engineered Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Human Genetically Engineered Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Human Genetically Engineered Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Human Genetically Engineered Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Genetically Engineered Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Genetically Engineered Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Human Genetically Engineered Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Genetically Engineered Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Genetically Engineered Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Genetically Engineered Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Human Genetically Engineered Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Human Genetically Engineered Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Human Genetically Engineered Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Human Genetically Engineered Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Human Genetically Engineered Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Human Genetically Engineered Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Human Genetically Engineered Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Human Genetically Engineered Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Human Genetically Engineered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Human Genetically Engineered Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Human Genetically Engineered Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Human Genetically Engineered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Human Genetically Engineered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Human Genetically Engineered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Human Genetically Engineered Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Human Genetically Engineered Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Human Genetically Engineered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Human Genetically Engineered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Human Genetically Engineered Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Human Genetically Engineered Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Human Genetically Engineered Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Human Genetically Engineered Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Human Genetically Engineered Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Human Genetically Engineered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Human Genetically Engineered Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Human Genetically Engineered Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Human Genetically Engineered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Human Genetically Engineered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Human Genetically Engineered Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Human Genetically Engineered Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Human Genetically Engineered Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Human Genetically Engineered Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Human Genetically Engineered Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Human Genetically Engineered Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Human Genetically Engineered Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Human Genetically Engineered Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Human Genetically Engineered Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Human Genetically Engineered Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Human Genetically Engineered Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Human Genetically Engineered Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Human Genetically Engineered Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Human Genetically Engineered Vaccine Price (US$/Unit) by Type (2020-2025)
Table 59. Global Human Genetically Engineered Vaccine Price (US$/Unit) by Type (2026-2031)
Table 60. Global Human Genetically Engineered Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Human Genetically Engineered Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Human Genetically Engineered Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Human Genetically Engineered Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Human Genetically Engineered Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Human Genetically Engineered Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Human Genetically Engineered Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Human Genetically Engineered Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Human Genetically Engineered Vaccine Price (US$/Unit) by Application (2020-2025)
Table 69. Global Human Genetically Engineered Vaccine Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Human Genetically Engineered Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck Human Genetically Engineered Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GSK Human Genetically Engineered Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Information
Table 86. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Description and Business Overview
Table 87. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Product
Table 89. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 90. Walvax Biotechnology Co., Ltd. Company Information
Table 91. Walvax Biotechnology Co., Ltd. Description and Business Overview
Table 92. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Product
Table 94. Walvax Biotechnology Co., Ltd. Recent Developments/Updates
Table 95. Bharat Biotech Company Information
Table 96. Bharat Biotech Description and Business Overview
Table 97. Bharat Biotech Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bharat Biotech Human Genetically Engineered Vaccine Product
Table 99. Bharat Biotech Recent Developments/Updates
Table 100. Chengdu Kanghua Biological Products Co., Ltd. Company Information
Table 101. Chengdu Kanghua Biological Products Co., Ltd. Description and Business Overview
Table 102. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Product
Table 104. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 105. South China Vaccine Corporation Limited Company Information
Table 106. South China Vaccine Corporation Limited Description and Business Overview
Table 107. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Product
Table 109. South China Vaccine Corporation Limited Recent Developments/Updates
Table 110. Beijing Health Guard Biotechnology Inc. Company Information
Table 111. Beijing Health Guard Biotechnology Inc. Description and Business Overview
Table 112. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Product
Table 114. Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
Table 115. CSL Limited Company Information
Table 116. CSL Limited Description and Business Overview
Table 117. CSL Limited Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. CSL Limited Human Genetically Engineered Vaccine Product
Table 119. CSL Limited Recent Developments/Updates
Table 120. Emergent BioSolutions Company Information
Table 121. Emergent BioSolutions Description and Business Overview
Table 122. Emergent BioSolutions Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Emergent BioSolutions Human Genetically Engineered Vaccine Product
Table 124. Emergent BioSolutions Recent Developments/Updates
Table 125. Sanofi Pasteur Company Information
Table 126. Sanofi Pasteur Description and Business Overview
Table 127. Sanofi Pasteur Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sanofi Pasteur Human Genetically Engineered Vaccine Product
Table 129. Sanofi Pasteur Recent Developments/Updates
Table 130. Serum Institute Company Information
Table 131. Serum Institute Description and Business Overview
Table 132. Serum Institute Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Serum Institute Human Genetically Engineered Vaccine Product
Table 134. Serum Institute Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Human Genetically Engineered Vaccine Distributors List
Table 138. Human Genetically Engineered Vaccine Customers List
Table 139. Human Genetically Engineered Vaccine Market Trends
Table 140. Human Genetically Engineered Vaccine Market Drivers
Table 141. Human Genetically Engineered Vaccine Market Challenges
Table 142. Human Genetically Engineered Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Human Genetically Engineered Vaccine
Figure 2. Global Human Genetically Engineered Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Human Genetically Engineered Vaccine Market Share by Type: 2024 & 2031
Figure 4. Genetic Recombinant Vaccine Product Picture
Figure 5. Recombinant Subunit Vaccines Product Picture
Figure 6. Genetic Vaccine Product Picture
Figure 7. Global Human Genetically Engineered Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Human Genetically Engineered Vaccine Market Share by Application: 2024 & 2031
Figure 9. Hepatitis E
Figure 10. Human Papillomavirus (HPV)
Figure 11. Rotavirus
Figure 12. Others
Figure 13. Global Human Genetically Engineered Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Human Genetically Engineered Vaccine Market Size (2020-2031) & (US$ Million)
Figure 15. Global Human Genetically Engineered Vaccine Sales (2020-2031) & (K Units)
Figure 16. Global Human Genetically Engineered Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 17. Human Genetically Engineered Vaccine Report Years Considered
Figure 18. Human Genetically Engineered Vaccine Sales Share by Manufacturers in 2024
Figure 19. Global Human Genetically Engineered Vaccine Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Human Genetically Engineered Vaccine Players: Market Share by Revenue in Human Genetically Engineered Vaccine in 2024
Figure 21. Human Genetically Engineered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Human Genetically Engineered Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Human Genetically Engineered Vaccine Sales Market Share by Country (2020-2031)
Figure 24. North America Human Genetically Engineered Vaccine Revenue Market Share by Country (2020-2031)
Figure 25. United States Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Human Genetically Engineered Vaccine Sales Market Share by Country (2020-2031)
Figure 28. Europe Human Genetically Engineered Vaccine Revenue Market Share by Country (2020-2031)
Figure 29. Germany Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Human Genetically Engineered Vaccine Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Human Genetically Engineered Vaccine Revenue Market Share by Region (2020-2031)
Figure 36. China Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Human Genetically Engineered Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Human Genetically Engineered Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Human Genetically Engineered Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Human Genetically Engineered Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Human Genetically Engineered Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Human Genetically Engineered Vaccine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Human Genetically Engineered Vaccine by Type (2020-2031)
Figure 55. Global Human Genetically Engineered Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Human Genetically Engineered Vaccine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Human Genetically Engineered Vaccine by Application (2020-2031)
Figure 58. Global Human Genetically Engineered Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 59. Human Genetically Engineered Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
